Breaking News Instant updates and real-time market news.

INGXF

Innergex Renewable Energy

$0.00 /

+ (+0.00%)

10:48
07/16/20
07/16
10:48
07/16/20
10:48

Innergex Renewable price target raised to C$22.50 from C$21.25 at Scotiabank

Scotiabank analyst Justin Strong raised the firm's price target on Innergex Renewable Energy to C$22.50 from C$21.25 and keeps a Sector Perform rating on the shares following the company acquiring the Class B shares of a portfolio of six operating wind energy projects located in Elmore County, Idaho.

INGXF Innergex Renewable Energy
$0.00 /

+ (+0.00%)

07/15/20 Scotiabank
Innergex Renewable price target raised to C$21.25 from C$20.50 at Scotiabank
06/04/20 National Bank
Innergex Renewable Energy price target raised to C$22.50 from C$21.50 at National Bank
05/15/20 Scotiabank
Innergex Renewable Energy price target raised to C$20.50 from C$20 at Scotiabank
01/13/20 BMO Capital
Innergex upgraded to Outperform from Market Perform at BMO Capital

TODAY'S FREE FLY STORIES

Options
Early notable gainers among liquid option names on August 4th » 09:55
08/04/20
08/04
09:55
08/04/20
09:55
MOS

Mosaic

$15.55 /

+1.85 (+13.50%)

, HST

Host Hotels

$10.25 /

-0.06 (-0.58%)

, AAL

American Airlines

$11.36 /

+0.27 (+2.43%)

, MHK

Mohawk

$83.75 /

+4.38 (+5.52%)

, CCL

Carnival

$13.52 /

+0.44 (+3.36%)

Notable gainers among…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOS Mosaic
$15.55 /

+1.85 (+13.50%)

HST Host Hotels
$10.25 /

-0.06 (-0.58%)

AAL American Airlines
$11.36 /

+0.27 (+2.43%)

MHK Mohawk
$83.75 /

+4.38 (+5.52%)

CCL Carnival
$13.52 /

+0.44 (+3.36%)

MOS Mosaic
$15.55 /

+1.85 (+13.50%)

07/15/20 Citi
Mosaic upgraded to Buy from Neutral at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 BofA
Mosaic upgraded to Buy from Underperform at BofA
05/11/20 BofA
Nutrien, Mosaic, Corteva, CF Industries cut to Underperform at BofA
HST Host Hotels
$10.25 /

-0.06 (-0.58%)

07/29/20 Morgan Stanley
Morgan Stanley upgrades Sunstone Hotel to Equal Weight after underperformance
07/29/20 Morgan Stanley
Morgan Stanley upgrades Host Hotels to Equal Weight following underperformance
07/29/20 Morgan Stanley
Host Hotels upgraded to Equal Weight from Underweight at Morgan Stanley
07/24/20 SunTrust
SunTrust cuts lodging REITs to Sell, Park Hotels double-downgraded from Buy
AAL American Airlines
$11.36 /

+0.27 (+2.43%)

07/28/20 Citi
Citi cuts American Airlines target to $11, opens negative catalyst watch
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Raymond James
American Airlines upgraded at Raymond James on balanced risk-reward
07/27/20 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
MHK Mohawk
$83.75 /

+4.38 (+5.52%)

07/28/20 Wells Fargo
Mohawk investigation adds 'layer of legitimacy' to lawsuit, says Wells Fargo
07/21/20 Loop Capital
Mohawk price target lowered to $75 from $90 at Loop Capital
07/14/20 Wells Fargo
Mohawk price target lowered to $70 from $80 at Wells Fargo
07/10/20 Jefferies
Mohawk could see short-lived relief rally after flooring data, says Jefferies
CCL Carnival
$13.52 /

+0.44 (+3.36%)

07/29/20 Berenberg
Berenberg upgrades Carnival plc to Hold, keeps Carnival Corp. at Sell
07/29/20 Berenberg
Carnival plc upgraded to Hold from Sell at Berenberg
07/21/20
Fly Intel: Top five analyst downgrades
07/21/20 HSBC
Carnival downgraded to Hold on cruise resumption risk at HSBC
MOS Mosaic
$15.55 /

+1.85 (+13.50%)

HST Host Hotels
$10.25 /

-0.06 (-0.58%)

AAL American Airlines
$11.36 /

+0.27 (+2.43%)

MHK Mohawk
$83.75 /

+4.38 (+5.52%)

CCL Carnival
$13.52 /

+0.44 (+3.36%)

  • 23
    Jun
  • 02
    Apr
AAL American Airlines
$11.36 /

+0.27 (+2.43%)

MHK Mohawk
$83.75 /

+4.38 (+5.52%)

CCL Carnival
$13.52 /

+0.44 (+3.36%)

MOS Mosaic
$15.55 /

+1.85 (+13.50%)

HST Host Hotels
$10.25 /

-0.06 (-0.58%)

AAL American Airlines
$11.36 /

+0.27 (+2.43%)

MHK Mohawk
$83.75 /

+4.38 (+5.52%)

CCL Carnival
$13.52 /

+0.44 (+3.36%)

MOS Mosaic
$15.55 /

+1.85 (+13.50%)

HST Host Hotels
$10.25 /

-0.06 (-0.58%)

AAL American Airlines
$11.36 /

+0.27 (+2.43%)

MHK Mohawk
$83.75 /

+4.38 (+5.52%)

CCL Carnival
$13.52 /

+0.44 (+3.36%)

Conference/Events
Morgan Stanley metals/commodities analysts hold analyst/industry conference call » 09:55
08/04/20
08/04
09:55
08/04/20
09:55

Global Commodities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
William Blair to hold a virtual conference » 09:55
08/04/20
08/04
09:55
08/04/20
09:55
RCUS

Arcus Biosciences

$20.42 /

-0.61 (-2.90%)

, AGEN

Agenus

$3.20 /

-0.055 (-1.69%)

, EXEL

Exelixis

$23.06 /

-0.64 (-2.70%)

, CALA

Calithera Biosciences

$4.85 /

-0.02 (-0.41%)

, RGEN

Repligen

$155.50 /

-3.02 (-1.91%)

, PIRS

Pieris Pharmaceuticals

$2.68 /

-0.025 (-0.92%)

, CYAD

Celyad

$9.87 /

+ (+0.00%)

, FATE

Fate Therapeutics

$32.33 /

-0.92 (-2.77%)

, CLLS

Cellectis

$17.44 /

+ (+0.00%)

, AUTL

Autolus Therapeutics

$13.92 /

+ (+0.00%)

, GRTS

Gritstone Oncology

$3.35 /

+0.03 (+0.90%)

, ADPT

Adaptive Biotechnologies

$39.49 /

+0.12 (+0.30%)

, TBIO

Translate Bio

$15.60 /

-0.14 (-0.89%)

, EBS

Emergent BioSolutions

$122.01 /

+4.045 (+3.43%)

, ITCI

Intra-Cellular

$20.77 /

-0.15 (-0.72%)

, KRTX

Karuna Therapeutics

$86.82 /

-0.68 (-0.78%)

, ASMB

Assembly Biosciences

$23.15 /

+0.03 (+0.13%)

, NCNA

NuCana

$6.55 /

+0.4 (+6.50%)

, AXSM

Axsome Therapeutics

$74.50 /

-1.82 (-2.38%)

, OVID

Ovid Therapeutics

$6.61 /

-0.16 (-2.36%)

, ALLK

Allakos

$78.92 /

-0.57 (-0.72%)

, NBIX

Neurocrine

$124.09 /

+0.92 (+0.75%)

, XENE

Xenon Pharmaceuticals

$11.51 /

+ (+0.00%)

, CRSP

Crispr Therapeutics

$91.70 /

-0.85 (-0.92%)

, BEAM

Beam Therapeutics

$19.00 /

+0.03 (+0.16%)

, GBT

Global Blood Therapeutics

$68.59 /

-2.08 (-2.94%)

, IONS

Ionis Pharmaceuticals

$58.45 /

-0.78 (-1.32%)

, RTRX

Retrophin

$20.19 /

+ (+0.00%)

Biotech Focus Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCUS Arcus Biosciences
$20.42 /

-0.61 (-2.90%)

AGEN Agenus
$3.20 /

-0.055 (-1.69%)

EXEL Exelixis
$23.06 /

-0.64 (-2.70%)

CALA Calithera Biosciences
$4.85 /

-0.02 (-0.41%)

RGEN Repligen
$155.50 /

-3.02 (-1.91%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.025 (-0.92%)

CYAD Celyad
$9.87 /

+ (+0.00%)

FATE Fate Therapeutics
$32.33 /

-0.92 (-2.77%)

CLLS Cellectis
$17.44 /

+ (+0.00%)

AUTL Autolus Therapeutics
$13.92 /

+ (+0.00%)

GRTS Gritstone Oncology
$3.35 /

+0.03 (+0.90%)

ADPT Adaptive Biotechnologies
$39.49 /

+0.12 (+0.30%)

TBIO Translate Bio
$15.60 /

-0.14 (-0.89%)

EBS Emergent BioSolutions
$122.01 /

+4.045 (+3.43%)

ITCI Intra-Cellular
$20.77 /

-0.15 (-0.72%)

KRTX Karuna Therapeutics
$86.82 /

-0.68 (-0.78%)

ASMB Assembly Biosciences
$23.15 /

+0.03 (+0.13%)

NCNA NuCana
$6.55 /

+0.4 (+6.50%)

AXSM Axsome Therapeutics
$74.50 /

-1.82 (-2.38%)

OVID Ovid Therapeutics
$6.61 /

-0.16 (-2.36%)

ALLK Allakos
$78.92 /

-0.57 (-0.72%)

NBIX Neurocrine
$124.09 /

+0.92 (+0.75%)

XENE Xenon Pharmaceuticals
$11.51 /

+ (+0.00%)

CRSP Crispr Therapeutics
$91.70 /

-0.85 (-0.92%)

BEAM Beam Therapeutics
$19.00 /

+0.03 (+0.16%)

GBT Global Blood Therapeutics
$68.59 /

-2.08 (-2.94%)

IONS Ionis Pharmaceuticals
$58.45 /

-0.78 (-1.32%)

RTRX Retrophin
$20.19 /

+ (+0.00%)

RCUS Arcus Biosciences
$20.42 /

-0.61 (-2.90%)

06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
06/03/20 SVB Leerink
Gilead upgraded to Outperform at SVB Leerink on remdesivir sales, Arcus deal
06/02/20 Citi
Arcus Biosciences price target raised to $41 from $15 at Citi
05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
AGEN Agenus
$3.20 /

-0.055 (-1.69%)

01/09/20 B. Riley FBR
Arbutus Biopharma price target raised to $6 from $3 at B. Riley FBR
11/19/19
Fly Intel: Top five analyst initiations
11/19/19 B. Riley FBR
Agenus resumed with a Buy at B. Riley FBR
11/19/19 B. Riley FBR
Agenus resumed with a Buy at B. Riley FBR
EXEL Exelixis
$23.06 /

-0.64 (-2.70%)

06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
05/13/20 Piper Sandler
Exelixis mCRPC data for CABOMETYX may accelerate approval, says Piper Sandler
05/06/20 Piper Sandler
Exelixis price target raised to $30 from $23 at Piper Sandler
CALA Calithera Biosciences
$4.85 /

-0.02 (-0.41%)

05/11/20 Citi
Calithera Biosciences price target raised to $10 from $7 at Citi
05/08/20 H.C. Wainwright
Calithera Biosciences price target raised to $9.50 from $7 at H.C. Wainwright
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 Jefferies
Jefferies starts Calithera at Buy ahead of three data catalysts
RGEN Repligen
$155.50 /

-3.02 (-1.91%)

06/30/20 H.C. Wainwright
Repligen price target raised to $151 from $143 at H.C. Wainwright
05/27/20 Stifel
Repligen price target raised to $150 from $135 at Stifel
05/07/20 Craig-Hallum
Repligen price target raised to $145 from $120 at Craig-Hallum
05/07/20 H.C. Wainwright
Repligen price target raised to $143 from $100 at H.C. Wainwright
PIRS Pieris Pharmaceuticals
$2.68 /

-0.025 (-0.92%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
CYAD Celyad
$9.87 /

+ (+0.00%)

03/26/20 Wells Fargo
Celyad price target lowered to $20 from $44 at Wells Fargo
03/25/20 H.C. Wainwright
Celyad price target lowered to $37 from $43 at H.C. Wainwright
FATE Fate Therapeutics
$32.33 /

-0.92 (-2.77%)

06/10/20 Oppenheimer
Fate Therapeutics price target raised to $40 from $34 at Oppenheimer
06/09/20 Piper Sandler
Fate Therapeutics price target lowered to $59 from $63 at Piper Sandler
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 H.C. Wainwright
Fate Therapeutics initiated with a Buy at H.C. Wainwright
CLLS Cellectis
$17.44 /

+ (+0.00%)

05/12/20
Fly Intel: Top five analyst initiations
05/11/20 Baird
Cellectis initiated with an Outperform at Baird
03/06/20 Citi
Cellectis price target raised to $16 from $14 at Citi
03/06/20 Goldman Sachs
Cellectis downgraded to Sell from Neutral at Goldman Sachs
AUTL Autolus Therapeutics
$13.92 /

+ (+0.00%)

07/31/20
Fly Intel: Top five analyst initiations
07/31/20 JPMorgan
Autolus Therapeutics initiated with an Overweight at JPMorgan
07/22/20 SunTrust
Autolus Therapeutics initiated with a Buy at SunTrust
07/22/20 SunTrust
Autolus Therapeutics initiated with a Buy at SunTrust
GRTS Gritstone Oncology
$3.35 /

+0.03 (+0.90%)

07/14/20 BTIG
Gritstone Oncology price target lowered to $17 from $31 at BTIG
ADPT Adaptive Biotechnologies
$39.49 /

+0.12 (+0.30%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
TBIO Translate Bio
$15.60 /

-0.14 (-0.89%)

07/07/20 H.C. Wainwright
Translate Bio price target raised to $32 from $18 at H.C. Wainwright
07/06/20
Fly Intel: Top five analyst initiations
07/06/20 William Blair
Translate Bio initiated with an Outperform at William Blair
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
EBS Emergent BioSolutions
$122.01 /

+4.045 (+3.43%)

07/17/20 Cantor Fitzgerald
Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 Raymond James
Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
ITCI Intra-Cellular
$20.77 /

-0.15 (-0.72%)

06/04/20 Cantor Fitzgerald
Cantor reiterates $37 target on Intra-Cellular ahead of Phase 3 data
03/03/20 BTIG
Intra-Cellular price target lowered to $68 from $73 at BTIG
02/20/20
Fly Intel: Top five analyst initiations
02/19/20 Evercore ISI
Intra-Cellular initiated with an Outperform at Evercore ISI
KRTX Karuna Therapeutics
$86.82 /

-0.68 (-0.78%)

06/24/20 Oppenheimer
Karuna Therapeutics price target raised to $135 from $125 at Oppenheimer
06/02/20 Wedbush
Karuna Therapeutics price target raised to $126 from $117 at Wedbush
06/01/20 Goldman Sachs
Karuna price target raised to $131 from $115 at Goldman Sachs
05/31/20 Stifel
Karuna schizophrenia drug has blockbuster potential, says Stifel
ASMB Assembly Biosciences
$23.15 /

+0.03 (+0.13%)

07/21/20 Baird
Assembly Biosciences HBV deal a positive, says Baird
07/20/20 Piper Sandler
BeiGene inked smart deal with Assembly, says Piper Sandler
06/02/20 Mizuho
New clinical paper potentially supports Assembly stoppage criteria, says Mizuho
10/17/19 Baird
Assembly Biosciences abstract data encouraging, says Baird
NCNA NuCana
$6.55 /

+0.4 (+6.50%)

07/24/20
Fly Intel: Top five analyst initiations
07/24/20 Oppenheimer
NuCana initiated with an Outperform at Oppenheimer
07/23/20 Oppenheimer
NuCana initiated with an Outperform at Oppenheimer
01/27/20 William Blair
NuCana undervalued as first patients dosed in Phase 3 study, says William Blair
AXSM Axsome Therapeutics
$74.50 /

-1.82 (-2.38%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
OVID Ovid Therapeutics
$6.61 /

-0.16 (-2.36%)

07/14/20 Citi
Ovid Therapeutics price target raised to $9 from $8 at Citi
06/18/20 Cantor Fitzgerald
Ovid Therapeutics price target raised to $13 from $7 at Cantor Fitzgerald
05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
ALLK Allakos
$78.92 /

-0.57 (-0.72%)

03/25/20 Jefferies
Allakos starts two pivotals on time despite skepticism, says Jefferies
03/12/20 SMBC Nikko
Allakos initiated with an Underperform at SMBC Nikko
02/27/20 Barclays
Allakos initiated with an Underweight at Barclays
02/27/20 Barclays
Allakos initiated with an Underweight at Barclays
NBIX Neurocrine
$124.09 /

+0.92 (+0.75%)

08:45 Today Canaccord
Neurocrine price target raised to $145 from $134 at Canaccord
08:04 Today SVB Leerink
Neurocrine price target raised to $120 from $105 at SVB Leerink
06:25 Today Piper Sandler
Neurocrine price target raised to $145 from $141 at Piper Sandler
06:17 Today H.C. Wainwright
Neurocrine price target raised to $140 from $131 at H.C. Wainwright
XENE Xenon Pharmaceuticals
$11.51 /

+ (+0.00%)

07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
07/20/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
06/01/20
Fly Intel: Top five analyst initiations
CRSP Crispr Therapeutics
$91.70 /

-0.85 (-0.92%)

07/28/20 Needham
Crispr Therapeutics price target raised to $105 from $84 at Needham
07/28/20 Wells Fargo
Crispr Therapeutics price target raised to $110 from $95 at Wells Fargo
07/28/20 Oppenheimer
Crispr Therapeutics price target raised to $105 from $89 at Oppenheimer
07/28/20 Barclays
Crispr Therapeutics price target raised to $102 from $65 at Barclays
BEAM Beam Therapeutics
$19.00 /

+0.03 (+0.16%)

03/02/20
Fly Intel: Top five analyst initiations
03/02/20 Wedbush
Wedbush bullish on Beam Therapeutics, initiates with an Outperform
03/02/20 JPMorgan
Beam Therapeutics initiated with an Overweight at JPMorgan
03/02/20 Wedbush
Beam Therapeutics initiated with an Outperform at Wedbush
GBT Global Blood Therapeutics
$68.59 /

-2.08 (-2.94%)

07/20/20 Roth Capital
Global Blood Therapeutics initiated with a Buy at Roth Capital
07/13/20 BofA
Global Blood Therapeutics initiated with a Buy at BofA
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/12/20 Wells Fargo
Global Blood's Oxbryta efficacy bar 'tough to surpass,' says Wells Fargo
IONS Ionis Pharmaceuticals
$58.45 /

-0.78 (-1.32%)

07/20/20 BMO Capital
Alnylam price target raised to $196 from $173 at BMO Capital
06/05/20 Citi
Ionis Pharmaceuticals price target raised to $80 from $71 at Citi
05/12/20 RBC Capital
Ionis Pharmaceuticals initiated with an Outperform at RBC Capital
04/22/20 Jefferies
Jefferies remains cautious on Ionis after report from partner Biogen
RTRX Retrophin
$20.19 /

+ (+0.00%)

07/13/20 BMO Capital
Retrophin price target lowered to $31 from $34 at BMO Capital
06/16/20 BTIG
Retrophin initiated with a Buy at BTIG
02/25/20 Barclays
Retrophin downgraded to Equal Weight from Overweight at Barclays
01/13/20 JMP Securities
JMP says continues to like Retrophin opportunity
RCUS Arcus Biosciences
$20.42 /

-0.61 (-2.90%)

AGEN Agenus
$3.20 /

-0.055 (-1.69%)

EXEL Exelixis
$23.06 /

-0.64 (-2.70%)

CALA Calithera Biosciences
$4.85 /

-0.02 (-0.41%)

RGEN Repligen
$155.50 /

-3.02 (-1.91%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.025 (-0.92%)

FATE Fate Therapeutics
$32.33 /

-0.92 (-2.77%)

CLLS Cellectis
$17.44 /

+ (+0.00%)

AUTL Autolus Therapeutics
$13.92 /

+ (+0.00%)

GRTS Gritstone Oncology
$3.35 /

+0.03 (+0.90%)

ADPT Adaptive Biotechnologies
$39.49 /

+0.12 (+0.30%)

TBIO Translate Bio
$15.60 /

-0.14 (-0.89%)

EBS Emergent BioSolutions
$122.01 /

+4.045 (+3.43%)

ITCI Intra-Cellular
$20.77 /

-0.15 (-0.72%)

KRTX Karuna Therapeutics
$86.82 /

-0.68 (-0.78%)

ASMB Assembly Biosciences
$23.15 /

+0.03 (+0.13%)

NCNA NuCana
$6.55 /

+0.4 (+6.50%)

AXSM Axsome Therapeutics
$74.50 /

-1.82 (-2.38%)

OVID Ovid Therapeutics
$6.61 /

-0.16 (-2.36%)

ALLK Allakos
$78.92 /

-0.57 (-0.72%)

NBIX Neurocrine
$124.09 /

+0.92 (+0.75%)

XENE Xenon Pharmaceuticals
$11.51 /

+ (+0.00%)

CRSP Crispr Therapeutics
$91.70 /

-0.85 (-0.92%)

BEAM Beam Therapeutics
$19.00 /

+0.03 (+0.16%)

GBT Global Blood Therapeutics
$68.59 /

-2.08 (-2.94%)

IONS Ionis Pharmaceuticals
$58.45 /

-0.78 (-1.32%)

RTRX Retrophin
$20.19 /

+ (+0.00%)

  • 16
    Jul
  • 01
    Jul
  • 26
    Jun
  • 09
    Jun
  • 09
    Jun
  • 29
    May
  • 13
    May
  • 16
    Apr
  • 06
    Feb
  • 24
    Jan
  • 23
    Jan
  • 23
    Jan
  • 22
    Jan
  • 08
    Jan
  • 19
    Dec
  • 12
    Dec
  • 21
    Nov
  • 21
    Nov
  • 04
    Oct
  • 18
    Sep
  • 12
    Sep
  • 12
    Sep
  • 07
    Aug
RCUS Arcus Biosciences
$20.42 /

-0.61 (-2.90%)

ALLK Allakos
$78.92 /

-0.57 (-0.72%)

RCUS Arcus Biosciences
$20.42 /

-0.61 (-2.90%)

EXEL Exelixis
$23.06 /

-0.64 (-2.70%)

CALA Calithera Biosciences
$4.85 /

-0.02 (-0.41%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.025 (-0.92%)

FATE Fate Therapeutics
$32.33 /

-0.92 (-2.77%)

CLLS Cellectis
$17.44 /

+ (+0.00%)

ADPT Adaptive Biotechnologies
$39.49 /

+0.12 (+0.30%)

TBIO Translate Bio
$15.60 /

-0.14 (-0.89%)

EBS Emergent BioSolutions
$122.01 /

+4.045 (+3.43%)

NCNA NuCana
$6.55 /

+0.4 (+6.50%)

AXSM Axsome Therapeutics
$74.50 /

-1.82 (-2.38%)

OVID Ovid Therapeutics
$6.61 /

-0.16 (-2.36%)

ALLK Allakos
$78.92 /

-0.57 (-0.72%)

NBIX Neurocrine
$124.09 /

+0.92 (+0.75%)

XENE Xenon Pharmaceuticals
$11.51 /

+ (+0.00%)

CRSP Crispr Therapeutics
$91.70 /

-0.85 (-0.92%)

BEAM Beam Therapeutics
$19.00 /

+0.03 (+0.16%)

GBT Global Blood Therapeutics
$68.59 /

-2.08 (-2.94%)

RCUS Arcus Biosciences
$20.42 /

-0.61 (-2.90%)

EXEL Exelixis
$23.06 /

-0.64 (-2.70%)

ITCI Intra-Cellular
$20.77 /

-0.15 (-0.72%)

AXSM Axsome Therapeutics
$74.50 /

-1.82 (-2.38%)

OVID Ovid Therapeutics
$6.61 /

-0.16 (-2.36%)

IONS Ionis Pharmaceuticals
$58.45 /

-0.78 (-1.32%)

Hot Stocks
4Front Ventures granted final state approval for adult-use cannabis sales » 09:53
08/04/20
08/04
09:53
08/04/20
09:53
FFNTF

4Front Ventures

$0.00 /

+ (+0.00%)

4Front Ventures announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FFNTF 4Front Ventures
$0.00 /

+ (+0.00%)

Hot Stocks
Booking Holdings to reduce Booking.com's global workforce by up to 25% » 09:51
08/04/20
08/04
09:51
08/04/20
09:51
BKNG

Booking Holdings

$1,644.25 /

-8.9 (-0.54%)

In a regulatory filing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKNG Booking Holdings
$1,644.25 /

-8.9 (-0.54%)

BKNG Booking Holdings
$1,644.25 /

-8.9 (-0.54%)

07/29/20 Jefferies
Booking Holdings price target raised to $1,600 from $1,300 at Jefferies
07/20/20 Goldman Sachs
Booking Holdings price target raised to $1,500 from $1,200 at Goldman Sachs
06/10/20 BTIG
Booking Holdings initiated with a Neutral at BTIG
06/03/20 Morgan Stanley
Booking, Expedia price targets raised at Morgan Stanley
BKNG Booking Holdings
$1,644.25 /

-8.9 (-0.54%)

BKNG Booking Holdings
$1,644.25 /

-8.9 (-0.54%)

BKNG Booking Holdings
$1,644.25 /

-8.9 (-0.54%)

Hot Stocks
Ralph Lauren sees gross margin expansion for the year  09:49
08/04/20
08/04
09:49
08/04/20
09:49
RL

Ralph Lauren

$66.01 /

-3.58 (-5.14%)

 
ShowHide Related Items >><<
RL Ralph Lauren
$66.01 /

-3.58 (-5.14%)

RL Ralph Lauren
$66.01 /

-3.58 (-5.14%)

07/20/20 Wells Fargo
Ralph Lauren price target lowered to $90 from $100 at Wells Fargo
06/22/20 RBC Capital
Ralph Lauren price target raised to $82 from $77 at RBC Capital
05/28/20 Needham
Ralph Lauren price target raised to $90 from $80 at Needham
05/28/20 Credit Suisse
Ralph Lauren price target raised to $89 from $82 at Credit Suisse
RL Ralph Lauren
$66.01 /

-3.58 (-5.14%)

RL Ralph Lauren
$66.01 /

-3.58 (-5.14%)

RL Ralph Lauren
$66.01 /

-3.58 (-5.14%)

Conference/Events
Rio Tinto participates in a conference call with Jefferies » 09:49
08/04/20
08/04
09:49
08/04/20
09:49
RIO

Rio Tinto

$61.79 /

-0.09 (-0.15%)

Basic Materials Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIO Rio Tinto
$61.79 /

-0.09 (-0.15%)

RIO Rio Tinto
$61.79 /

-0.09 (-0.15%)

07/30/20 JPMorgan
Rio Tinto price target raised to 5,590 GBp from 5,500 GBp at JPMorgan
07/30/20 Deutsche Bank
Rio Tinto price target raised to 5,000 GBp from 4,900 GBp at Deutsche Bank
07/30/20 Investec
Rio Tinto downgraded to Hold from Buy at Investec
07/20/20 JPMorgan
Rio Tinto price target raised to 5,500 GBp from 5,440 GBp at JPMorgan
RIO Rio Tinto
$61.79 /

-0.09 (-0.15%)

RIO Rio Tinto
$61.79 /

-0.09 (-0.15%)

RIO Rio Tinto
$61.79 /

-0.09 (-0.15%)

Hot Stocks
JanOne changes internal drug candidate name to JAN101 from TV1001SR » 09:49
08/04/20
08/04
09:49
08/04/20
09:49
JAN

JanOne

$4.22 /

+ (+0.00%)

JanOne announces a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAN JanOne
$4.22 /

+ (+0.00%)

Hot Stocks
Arconic falls -9.0% » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
ARNC

Arconic

$16.00 /

-1.25 (-7.25%)

Arconic is down -9.0%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARNC Arconic
$16.00 /

-1.25 (-7.25%)

ARNC Arconic
$16.00 /

-1.25 (-7.25%)

05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Credit Suisse
Arconic initiated with an Outperform at Credit Suisse
04/01/20 Cowen
Howmet Aerospace price target lowered to $17 from $23 at Cowen
03/20/20 Barclays
Arconic downgraded to Equal Weight from Overweight at Barclays
ARNC Arconic
$16.00 /

-1.25 (-7.25%)

ARNC Arconic
$16.00 /

-1.25 (-7.25%)

ARNC Arconic
$16.00 /

-1.25 (-7.25%)

Hot Stocks
Virgin Galactic falls -9.1% » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
SPCE

Virgin Galactic

$21.61 /

-2.415 (-10.05%)

Virgin Galactic is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPCE Virgin Galactic
$21.61 /

-2.415 (-10.05%)

SPCE Virgin Galactic
$21.61 /

-2.415 (-10.05%)

07/13/20 Alembic Global
Virgin Galactic initiated with an Overweight at Alembic Global
03/24/20 Morgan Stanley
Morgan Stanley upgrades Virgin Galactic to Overweight after over 70% drop
03/24/20 Morgan Stanley
Virgin Galactic upgraded to Overweight from Equal Weight at Morgan Stanley
03/03/20 Morgan Stanley
Lead up to next lunar landings can have 'powerful impact,' says Morgan Stanley
SPCE Virgin Galactic
$21.61 /

-2.415 (-10.05%)

  • 06
    Aug
  • 03
    Jun
  • 20
    May
SPCE Virgin Galactic
$21.61 /

-2.415 (-10.05%)

SPCE Virgin Galactic
$21.61 /

-2.415 (-10.05%)

SPCE Virgin Galactic
$21.61 /

-2.415 (-10.05%)

Hot Stocks
Edgewell Personal Care falls -9.0% » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
EPC

Edgewell Personal Care

$28.02 /

-2.89 (-9.35%)

Edgewell Personal Care is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPC Edgewell Personal Care
$28.02 /

-2.89 (-9.35%)

EPC Edgewell Personal Care
$28.02 /

-2.89 (-9.35%)

02/28/20
Fly Intel: Top five analyst initiations
02/28/20 Goldman Sachs
Edgewell Personal Care reinstated with a Conviction Buy at Goldman Sachs
02/11/20 SunTrust
Edgewell Personal Care price target raised to $45 from $40 at SunTrust
02/10/20 Citi
Edgewell Personal Care downgraded to Neutral from Buy at Citi
EPC Edgewell Personal Care
$28.02 /

-2.89 (-9.35%)

EPC Edgewell Personal Care
$28.02 /

-2.89 (-9.35%)

Recommendations
Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
VYGR

Voyager Therapeutics

$11.36 /

+ (+0.00%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYGR Voyager Therapeutics
$11.36 /

+ (+0.00%)

VYGR Voyager Therapeutics
$11.36 /

+ (+0.00%)

03/30/20 Nomura Instinet
Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet
03/19/20
Fly Intel: Top five analyst initiations
03/19/20 Benchmark
Benchmark starts Voyager Therapeutics at Buy with $18 price target
03/19/20 Benchmark
Voyager Therapeutics initiated with a Buy at Benchmark
VYGR Voyager Therapeutics
$11.36 /

+ (+0.00%)

Hot Stocks
Grupo Supervielle rises 13.3% » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
SUPV

Grupo Supervielle

$3.22 /

+ (+0.00%)

Grupo Supervielle is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SUPV Grupo Supervielle
$3.22 /

+ (+0.00%)

SUPV Grupo Supervielle
$3.22 /

+ (+0.00%)

12/09/19 Itau BBA
Grupo Supervielle downgraded to Underperform from Market Perform at Itau BBA
09/19/19
Grupo Supervielle, Banco Macro cut to Underperform at BofA/Merrill
09/19/19 BofA/Merrill
Grupo Supervielle downgraded to Underperform from Neutral at BofA/Merrill
08/12/19 Morgan Stanley
Morgan Stanley double downgrades four Argentina banks after election surprise
Hot Stocks
Danaos rises 18.5% » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
DAC

Danaos

$4.35 /

+0.69 (+18.85%)

Danaos is up 18.5%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DAC Danaos
$4.35 /

+0.69 (+18.85%)

DAC Danaos
$4.35 /

+0.69 (+18.85%)

12/03/19
Fly Intel: Top five analyst upgrades
12/03/19 Jefferies
Jefferies upgrades Danaos to Buy with equity raise overhang removed
12/03/19 Jefferies
Danaos upgraded to Buy from Hold at Jefferies
  • 22
    Nov
Hot Stocks
BlueLinx rises 19.3% » 09:47
08/04/20
08/04
09:47
08/04/20
09:47
BXC

BlueLinx

$17.39 /

+2.93 (+20.26%)

BlueLinx is up 19.3%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BXC BlueLinx
$17.39 /

+2.93 (+20.26%)

BXC BlueLinx
$17.39 /

+2.93 (+20.26%)

08:24 Today B. Riley FBR
B. Riley FBR upgrades BlueLinx on Q2 beat, boosts target to $19
04:45 Today B. Riley FBR
BlueLinx upgraded to Buy from Neutral at B. Riley FBR
07/15/20 B. Riley FBR
BlueLinx price target raised to $9 from $6 at B. Riley FBR
04/09/20 B. Riley FBR
BlueLinx downgraded to Neutral with $6 price target at B. Riley FBR
BXC BlueLinx
$17.39 /

+2.93 (+20.26%)

BXC BlueLinx
$17.39 /

+2.93 (+20.26%)

Periodicals
SEC investigating Texas hotelier Monty Bennett's companies, WSJ reports » 09:45
08/04/20
08/04
09:45
08/04/20
09:45
AHT

Ashford Hospitality

$3.59 /

-0.14 (-3.75%)

, AINC

Ashford

$6.03 /

+ (+0.00%)

, BHR

Braemar Hotels & Resorts

$2.49 /

+ (+0.00%)

The Securities and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHT Ashford Hospitality
$3.59 /

-0.14 (-3.75%)

BHR Braemar Hotels & Resorts
$2.49 /

+ (+0.00%)

AHT Ashford Hospitality
$3.59 /

-0.14 (-3.75%)

06/17/20
Fly Intel: Top five analyst upgrades
06/17/20 DA Davidson
Ashford Hospitality upgraded to Neutral from Underperform at DA Davidson
04/06/20 B. Riley FBR
Ashford Hospitality downgraded to Neutral from Buy at B. Riley FBR
03/10/20 DA Davidson
Ashford Hospitality downgraded to Underperform from Neutral at DA Davidson
AINC Ashford
$6.03 /

+ (+0.00%)

06/26/20 B. Riley FBR
Ashford price target raised to $12 from $10 at B. Riley FBR
04/06/20 B. Riley FBR
Ashford downgraded to Neutral from Buy at B. Riley FBR
11/22/19 B. Riley FBR
Ashford price target lowered to $42 from $59 at B. Riley FBR
BHR Braemar Hotels & Resorts
$2.49 /

+ (+0.00%)

06/05/20 B. Riley FBR
Braemar Hotels downgraded to Neutral on valuaton at B. Riley FBR
06/05/20 B. Riley FBR
Braemar Hotels & Resorts downgraded to Neutral from Buy at B. Riley FBR
03/10/20 DA Davidson
Braemar Hotels & Resorts downgraded to Neutral from Buy at DA Davidson
03/10/20 DA Davidson
Braemar Hotels & Resorts downgraded to Neutral from Buy at DA Davidson
AHT Ashford Hospitality
$3.59 /

-0.14 (-3.75%)

AINC Ashford
$6.03 /

+ (+0.00%)

General news
Factory Orders to be reported at 10:00 » 09:45
08/04/20
08/04
09:45
08/04/20
09:45

June Factory Orders will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Jefferies healthcare services analyst to hold analyst/industry conference call » 09:44
08/04/20
08/04
09:44
08/04/20
09:44

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Chegg price target raised to $95 from $60 at Barrington » 09:43
08/04/20
08/04
09:43
08/04/20
09:43
CHGG

Chegg

$85.94 /

+ (+0.00%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

09:41 Today Citi
Citi upgrades Chegg to Buy with $100 target after Q2 beat
09:35 Today Citi
Chegg upgraded to Buy from Neutral at Citi
09:34 Today Needham
Chegg price target raised to $100 from $70 at Needham
09:25 Today BMO Capital
Chegg price target raised to $91 from $67 at BMO Capital
CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

Upgrade
Citi upgrades Chegg to Buy with $100 target after Q2 beat » 09:41
08/04/20
08/04
09:41
08/04/20
09:41
CHGG

Chegg

$85.94 /

+ (+0.00%)

Citi analyst Nithin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

09:35 Today Citi
Chegg upgraded to Buy from Neutral at Citi
09:34 Today Needham
Chegg price target raised to $100 from $70 at Needham
09:25 Today BMO Capital
Chegg price target raised to $91 from $67 at BMO Capital
08:58 Today Craig-Hallum
Chegg price target raised to $105 from $65 at Craig-Hallum
CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

CHGG Chegg
$85.94 /

+ (+0.00%)

Options
Unusually active option classes on open August 4th » 09:40
08/04/20
08/04
09:40
08/04/20
09:40
PSTG

Pure Storage

$18.11 /

+ (+0.00%)

, ARCC

Ares Capital

$14.44 /

+ (+0.00%)

, ADT

ADT Inc.

$13.42 /

+ (+0.00%)

, BP

BP

$22.09 /

+ (+0.00%)

, VALE

Vale

$11.43 /

+ (+0.00%)

, AZN

AstraZeneca

$56.80 /

+ (+0.00%)

, INTC

Intel

$48.29 /

+ (+0.00%)

, PINS

Pinterest

$36.07 /

+ (+0.00%)

, MO

Altria Group

$41.00 /

+ (+0.00%)

Unusual total active…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSTG Pure Storage
$18.11 /

+ (+0.00%)

ARCC Ares Capital
$14.44 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

06/18/20 Deutsche Bank
Pure Storage initiated with a Hold at Deutsche Bank
06/17/20 Deutsche Bank
Pure Storage initiated with a Hold at Deutsche Bank
05/29/20 Lake Street
Pure Storage a share gainer with 'robust' subscription growth, says Lake Street
05/29/20 Northland
Pure Storage price target raised to $23 from $21 at Northland
ARCC Ares Capital
$14.44 /

+ (+0.00%)

05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Ares Capital upgraded to Buy from Neutral at BofA
ADT ADT Inc.
$13.42 /

+ (+0.00%)

08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
08/03/20 William Blair
Alarm.com downgraded at William Blair on ADT/Google overhang
08/03/20 William Blair
Alarm.com downgraded to Market Perform from Outperform at William Blair
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
BP BP
$22.09 /

+ (+0.00%)

07/16/20 Jefferies
BP upgraded to Buy from Hold at Jefferies
07/15/20 JPMorgan
BP price target raised to 425 GBp from 400 GBp at JPMorgan
07/14/20 Credit Suisse
BP price target lowered to 350 GBp from 360 GBp at Credit Suisse
07/01/20 Barclays
BP price target raised to 400 GBp from 380 GBp at Barclays
VALE Vale
$11.43 /

+ (+0.00%)

06/11/20 Deutsche Bank
Vale price target raised to $13 from $11 at Deutsche Bank
06/09/20 GLJ Research
Fortescue Metals upgraded to Hold from Sell at GLJ Research
06/05/20 Exane BNP Paribas
Vale upgraded to Outperform from Neutral at Exane BNP Paribas
06/03/20 UBS
Vale upgraded to Buy from Neutral at UBS
AZN AstraZeneca
$56.80 /

+ (+0.00%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
INTC Intel
$48.29 /

+ (+0.00%)

07:28 Today Jefferies
AMD price target raised to $95 from $86 at Jefferies
08/03/20 Roth Capital
MaxLinear price target raised to $35 from $30 at Roth Capital
08/03/20 Stifel
Stifel rises MaxLinear price target to $35 after completion of Home Gateway deal
07/31/20 Erste
Intel downgraded to Hold from Buy at Erste
PINS Pinterest
$36.07 /

+ (+0.00%)

08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Wedbush
Pinterest price target raised to $39 from $31 at Wedbush
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
08/03/20 JPMorgan
Pinterest price target raised to $37 from $26 at JPMorgan
MO Altria Group
$41.00 /

+ (+0.00%)

07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Barclays
Altria downgraded to Equal Weight on share losses at Barclays
07/08/20 Barclays
Altria Group downgraded to Equal Weight from Overweight at Barclays
07/07/20 Stifel
IQOS reduced exposure claim a 'win' for Philip Morris, Altria, says Stifel
PSTG Pure Storage
$18.11 /

+ (+0.00%)

ARCC Ares Capital
$14.44 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

  • 16
    Oct
PSTG Pure Storage
$18.11 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

PSTG Pure Storage
$18.11 /

+ (+0.00%)

ARCC Ares Capital
$14.44 /

+ (+0.00%)

ADT ADT Inc.
$13.42 /

+ (+0.00%)

BP BP
$22.09 /

+ (+0.00%)

VALE Vale
$11.43 /

+ (+0.00%)

AZN AstraZeneca
$56.80 /

+ (+0.00%)

INTC Intel
$48.29 /

+ (+0.00%)

PINS Pinterest
$36.07 /

+ (+0.00%)

MO Altria Group
$41.00 /

+ (+0.00%)

Recommendations
Pitney Bowes price target raised to $6 from $5 at National Securities » 09:39
08/04/20
08/04
09:39
08/04/20
09:39
PBI

Pitney Bowes

$4.90 /

+1.57 (+47.15%)

National Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBI Pitney Bowes
$4.90 /

+1.57 (+47.15%)

PBI Pitney Bowes
$4.90 /

+1.57 (+47.15%)

08/03/20 National Securities
Pitney Bowes upgraded to Buy from Neutral at National Securities
05/05/20 National Securities
Pitney Bowes downgraded to Neutral from Buy at National Securities
10/24/19
Fly Intel: Top five analyst initiations
10/24/19 National Securities
Pitney Bowes initiated with a Buy at National Securities
PBI Pitney Bowes
$4.90 /

+1.57 (+47.15%)

PBI Pitney Bowes
$4.90 /

+1.57 (+47.15%)

Syndicate
Carlyle Group 1.45M share Block Trade priced at $27.90 » 09:38
08/04/20
08/04
09:38
08/04/20
09:38
CG

Carlyle Group

$28.32 /

-0.14 (-0.49%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CG Carlyle Group
$28.32 /

-0.14 (-0.49%)

CG Carlyle Group
$28.32 /

-0.14 (-0.49%)

06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Carlyle Group downgraded to Neutral from Buy at Citi
04/15/20
Fly Intel: Top five analyst upgrades
04/15/20 Citi
Carlyle Group upgraded to Buy from Neutral at Citi
CG Carlyle Group
$28.32 /

-0.14 (-0.49%)

CG Carlyle Group
$28.32 /

-0.14 (-0.49%)

CG Carlyle Group
$28.32 /

-0.14 (-0.49%)

CG Carlyle Group
$28.32 /

-0.14 (-0.49%)

Downgrade
JPMorgan downgrades Mimecast to Underweight on lack of catalysts » 09:37
08/04/20
08/04
09:37
08/04/20
09:37
MIME

Mimecast

$46.76 /

-0.17 (-0.36%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIME Mimecast
$46.76 /

-0.17 (-0.36%)

MIME Mimecast
$46.76 /

-0.17 (-0.36%)

08:36 Today Monness Crespi
Mimecast price target raised to $56 from $50 at Monness Crespi
08:18 Today RBC Capital
Mimecast price target raised to $53 from $48 at RBC Capital
07:43 Today Oppenheimer
Mimecast price target raised to $53 from $48 at Oppenheimer
06:56 Today Barclays
Mimecast price target raised to $61 from $48 at Barclays
MIME Mimecast
$46.76 /

-0.17 (-0.36%)

MIME Mimecast
$46.76 /

-0.17 (-0.36%)

Earnings
Alpha Pro Tech reports Q2 EPS 46c vs. 8c last year » 09:37
08/04/20
08/04
09:37
08/04/20
09:37
APT

Alpha Pro Tech

$24.84 /

+2.98 (+13.63%)

Reports Q2 revenue $25.5M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APT Alpha Pro Tech
$24.84 /

+2.98 (+13.63%)

APT Alpha Pro Tech
$24.84 /

+2.98 (+13.63%)

APT Alpha Pro Tech
$24.84 /

+2.98 (+13.63%)

APT Alpha Pro Tech
$24.84 /

+2.98 (+13.63%)

APT Alpha Pro Tech
$24.84 /

+2.98 (+13.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.